Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Epithelial-mesenchymal interactions in pulmonary fibrosis.

Chapman HA.

Annu Rev Physiol. 2011;73:413-35. doi: 10.1146/annurev-physiol-012110-142225. Review.

PMID:
21054168
2.

Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells.

Yamada A, Aki T, Unuma K, Funakoshi T, Uemura K.

PLoS One. 2015 Mar 23;10(3):e0120192. doi: 10.1371/journal.pone.0120192. eCollection 2015.

3.

Epithelial responses to lung injury: role of the extracellular matrix.

Chapman HA.

Proc Am Thorac Soc. 2012 Jul;9(3):89-95. doi: 10.1513/pats.201112-053AW.

PMID:
22802280
4.

Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.

Barker TH, Dysart MM, Brown AC, Douglas AM, Fiore VF, Russell AG; HEI Health Review Committee..

Res Rep Health Eff Inst. 2014 Nov;(182):3-41.

PMID:
25669020
5.

The differential expression of TGF-β1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study.

Kim MK, Maeng YI, Sung WJ, Oh HK, Park JB, Yoon GS, Cho CH, Park KK.

Int J Clin Exp Pathol. 2013 Aug 15;6(9):1747-58. eCollection 2013.

6.

The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells.

Yamada M, Kubo H, Ota C, Takahashi T, Tando Y, Suzuki T, Fujino N, Makiguchi T, Takagi K, Suzuki T, Ichinose M.

Respir Res. 2013 Sep 24;14:95. doi: 10.1186/1465-9921-14-95.

7.

Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.

Zhang YQ, Liu YJ, Mao YF, Dong WW, Zhu XY, Jiang L.

Clin Nutr. 2015 Aug;34(4):752-60. doi: 10.1016/j.clnu.2014.08.014. Epub 2014 Sep 6.

PMID:
25234611
8.

Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway.

Chen T, Nie H, Gao X, Yang J, Pu J, Chen Z, Cui X, Wang Y, Wang H, Jia G.

Toxicol Lett. 2014 Apr 21;226(2):150-62. doi: 10.1016/j.toxlet.2014.02.004. Epub 2014 Feb 12.

PMID:
24530353
9.

Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue.

Xu X, Wan X, Geng J, Li F, Wang C, Dai H.

Int J Mol Med. 2013 Aug;32(2):430-8. doi: 10.3892/ijmm.2013.1415. Epub 2013 Jun 11.

PMID:
23760654
10.

High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.

Li LC, Li DL, Xu L, Mo XT, Cui WH, Zhao P, Zhou WC, Gao J, Li J.

J Pharmacol Exp Ther. 2015 Sep;354(3):302-9. doi: 10.1124/jpet.114.222372. Epub 2015 Jun 30.

11.

Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.

Tang H, He H, Ji H, Gao L, Mao J, Liu J, Lin H, Wu T.

J Surg Res. 2015 Jul;197(1):167-75. doi: 10.1016/j.jss.2015.02.062. Epub 2015 Mar 13.

PMID:
25911951
12.

IGFBP-5 enhances epithelial cell adhesion and protects epithelial cells from TGFβ1-induced mesenchymal invasion.

Vijayan A, Guha D, Ameer F, Kaziri I, Mooney CC, Bennett L, Sureshbabu A, Tonner E, Beattie J, Allan GJ, Edwards J, Flint DJ.

Int J Biochem Cell Biol. 2013 Dec;45(12):2774-85. doi: 10.1016/j.biocel.2013.10.001. Epub 2013 Oct 11.

PMID:
24120850
13.

Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms.

Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma YG, Wang XX, Liu HZ, Sun W, Hu ZW.

J Immunol. 2011 Sep 15;187(6):3003-14. doi: 10.4049/jimmunol.1004081. Epub 2011 Aug 12. Erratum in: J Immunol. 2014 Nov 15;193(10):5345-6.

14.

Integrin-linked kinase (ILK) in pulmonary fibrosis.

Kavvadas P, Kypreou KP, Protopapadakis E, Prodromidi E, Sideras P, Charonis AS.

Virchows Arch. 2010 Nov;457(5):563-75. doi: 10.1007/s00428-010-0976-7. Epub 2010 Sep 21.

PMID:
20857141
15.

Epithelial origin of myofibroblasts during fibrosis in the lung.

Willis BC, duBois RM, Borok Z.

Proc Am Thorac Soc. 2006 Jun;3(4):377-82. Review.

16.

Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.

Kang M, Choi S, Jeong SJ, Lee SA, Kwak TK, Kim H, Jung O, Lee MS, Ko Y, Ryu J, Choi YJ, Jeong D, Lee HJ, Ye SK, Kim SH, Lee JW.

Biochem J. 2012 May 1;443(3):691-700. doi: 10.1042/BJ20111584.

PMID:
22292774
17.

Involvement of epithelial-to-mesenchymal transition and associated transforming growth factor-β/Smad signaling in paraquat-induced pulmonary fibrosis.

Han YY, Shen P, Chang WX.

Mol Med Rep. 2015 Dec;12(6):7979-84. doi: 10.3892/mmr.2015.4454. Epub 2015 Oct 19.

18.

The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells.

Sides MD, Klingsberg RC, Shan B, Gordon KA, Nguyen HT, Lin Z, Takahashi T, Flemington EK, Lasky JA.

Am J Respir Cell Mol Biol. 2011 Jun;44(6):852-62. doi: 10.1165/rcmb.2009-0232OC. Epub 2010 Aug 6.

19.

Epithelial to mesenchymal transition (EMT) induced by bleomycin or TFG(b1)/EGF in murine induced pluripotent stem cell-derived alveolar Type II-like cells.

Alipio ZA, Jones N, Liao W, Yang J, Kulkarni S, Sree Kumar K, Hauer-Jensen M, Ward DC, Ma Y, Fink LM.

Differentiation. 2011 Sep;82(2):89-98. doi: 10.1016/j.diff.2011.05.001. Epub 2011 May 18.

PMID:
21596473
20.

AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.

Xu MY, Chen R, Yu JX, Liu T, Qu Y, Lu LG.

Cancer Lett. 2016 May 1;374(2):241-9. doi: 10.1016/j.canlet.2016.02.025. Epub 2016 Feb 20.

PMID:
26902423

Supplemental Content

Support Center